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Abstract
Purpose To assess how vitamin D status is associated
with health-related quality of life (HRQOL) among older
residents of Canada.
Design We analysed baseline data of 1,493 Canadians
aged 50 years and over in Alberta on HRQOL (EQ-5D-5L)
and serum 25-hydroxyvitamin D (25(OH)D) as a measure
of vitamin D status. We applied multivariable regression
methods to examine the association between vitamin D
status and each of the five dimensions and the summary
index of the EQ-5D-5L.
Results Participants with higher serum 25(OH)D levels
were significantly less likely to report problems with
mobility, usual activities, and depression and anxiety. Spe-
cifically, age- and gender-adjusted odds ratios for reporting
problems with mobility, usual activities, and depression and
anxiety were 0.58 (95 % confidence interval 0.44–0.78),
0.67 (0.50–0.89), and 0.67 (0.51–0.88) per 100 nmol/L
increase in 25(OH)D, respectively. No significant associa-
tions were observed for problems with self-care and with
pain and discomfort. HRQOL scores combining the
responses of each of the five dimensions increased signifi-
cantly with increasing serum 25(OH)D levels.
Conclusions This is the first study to reveal the impor-
tance of vitamin D for the five dimensions of HRQOL in a
community-based sample. The observed associations of
vitamin D and HRQOL call for intervention studies to
strengthen the evidence of the potential benefits of vitamin
D supplementation for HRQOL among older adults.
Keywords Health-related quality of life  Vitamin D 
Public health  Disease prevention
Introduction
Vitamin D has been shown to affect bone health and var-
ious chronic diseases [1]. To mediate on the burden of
some of these conditions, the Institute of Medicine and
Health Canada recommend vitamin D supplementation of
600 IU per day for adults and 800 IU per day for those
above the age of 70 years [2, 3]. Supplementation may be
particularly important to residents of northern geographies,
such as Canada, as subcutaneous creation of vitamin D by
sun exposure is limited [4]. In Canada, vitamin D defi-
ciency and insufficiency continue to be prevalent despite
the recommendations for Vitamin D supplementation [5].
Specifically, the Canadian Health Measures Survey had
shown that 4.1 and 10.6 % (95 % confidence interval
2.9–5.8 and 8.2–13.6 %, respectively) of Canadians aged
6–79 years had serum 25-hydroxyvitamin D \27.5 and
37.5 nmol/L, respectively [5]. We recently showed that the
rates of deficiency and insufficiency were 3 and 8 %,
respectively, in a sample of working age Canadians [6].
For older populations, several vitamin D supplementa-
tion studies have suggested, though not consistently, less
functional limitation [7], prevention of falls [8–10],
reductions in fractures [11–13], and mental health benefits
[14, 15]. A meta-analysis by Bischoff-Ferrari et al. [9]
concluded that in order to achieve a reduction in falls a
supplementation dose of 700–1,000 IU per day is needed
which is close to what is currently recommended by the
Institute of Medicine. The above studies suggest a rela-
tionship of vitamin D and objectively measured health
conditions. Health-related quality of life (HRQOL) aims to
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quantify the subjective experiences of the consequences of
these health conditions. The importance of vitamin D for
HRQOL has been less studied. Huang et al. [16] attributed
improvements in quality of life along with improvements
in pain and sleep to vitamin D supplementation in a case
series of individuals with chronic pain. However, to the
best of our knowledge, no earlier studies have examined
the association of vitamin D with the full spectrum of
HRQOL in healthy populations. We believe that this is
particularly important as the Institute of Medicine recom-
mendations are issued to the general public. We also
believe these are particular important to Canadians given
the relatively high latitude and consequent reliance on
vitamin D from diet and supplements. In the present study,
we assess the association of vitamin D status and HRQOL
among older residents of Canada.
Methods
This is a cross-sectional study based on information
gathered at baseline visits from volunteer participants
before starting a wellness programme by the Pure North
S’Energy Foundation (PN). PN, a charitable, not-for-
profit organization, provides a lifestyle counselling
programme as described in more detail elsewhere [6,
17, 18]. As of August of 2012, PN started the recruit-
ment of older residents of the city of Calgary, Alberta,
Canada. PN advertised their programme for seniors
through local newsletters and through the distribution of
flyers in senior homes and community centres. PN
would organize weekly information meetings after
which attendees could elect to sign up to enrol the
programme. The present study pertains to baseline
observations of older residents recruited between
August 2012 and April 2013.
At their baseline visit, participants completed a survey
had their body height and weight measured and their blood
drawn for the assessment of serum 25-hydroxyvitamin D
(25(OH)D). The survey included the five-level EQ-5D
(EQ-5D-5L) to measure health-related quality of life
(HRQOL) [19]. The EQ-5D consists of a five-dimensional
descriptive system asking whether participants have (1) no
problems; (2) slight problems; (3) moderate problems; (4)
severe problems; or (5) extreme conditions or are unable to
perform or extreme conditions are fully constrained or
restricted, with each of the following: (1) mobility; (2) self-
care; (3) usual activities; (4) pain or discomfort; and (5)
anxiety or depression [19]. HRQOL scores are based on
responses to each of the five dimensions and were derived
from the USA value sets [20]. The EQ-5D is an established
and validated instrument [19] with the major advantages of
being short and easy to complete [21].
The survey further included questions on age, gender,
and income. Individuals and couples with an annual
income of \$25,000 and of \$41,000, respectively [22],
were considered as low income. Body mass index (BMI)
was calculated on the basis of the measured heights and
weights (weights in kilograms divided by the square of
height in metres). Individuals with a BMI of 25 or more are
considered overweight, and those with a BMI of 30 or more
are considered obese [23].
Serum 25(OH)D is the established proxy for vitamin D
status. Some have suggested that individuals with serum
25(OH)D levels below 25 nmol/L should be considered
vitamin D deficiency and those with serum 25(OH)D levels
of 25 or more and \50 nmol/L be considered vitamin D
insufficiency. As recent studies have suggested extra-
skeletal benefits, such as reduction in colorectal cancer and
cardiovascular disease risk, for individuals with serum
levels of 75 nmol/L or more [1, 24, 25], and given the large
number of observations with serum levels above 75 nmol/L,
we further categorized serum levels into C75 and \100,
C100 and \125, and C125 nmol/L.
As descriptive statistics, we included the prevalence of
problems in the five HRQOL dimensions by vitamin D
category and by age, gender, income, and bodyweight
status. We tested for differences in the prevalence of
HRQOL problems across vitamin D status categories by
the use of univariate logistic regression. We applied uni-
variate and multivariable logistic regression to quantify the
association of vitamin D status with problems in each of
the five HRQOL domains whereby we had dichotomized
the latter into ‘having no problems’ (level 1) and ‘having
problems’ (levels 2–5 combined). As HRQOL scores were
skewed to the left, with values ranging from 0.129 to 1.0,
we log-transformed inverse of the HRQOL scores, i.e.
log10(1.0001 - HRQOL). These ‘log of inverse HRQOL
scores’ increase with poorer HRQOL and constitute the
dependent variables in univariate and multivariable linear
regression analyses to quantify the significance of vitamin
D status for overall HRQOL. p values \0.05 were con-
sidered statistically significant.
PN anonymized their data prior to forwarding it to the
University of Alberta for statistical analysis. The analysis
was conducted using STATA version 12 (College Station,
Texas). The Human Research Ethics Board of the Uni-
versity of Alberta approved the data access and analysis for
this study.
Results
The mean serum 25(OH)D level among the 1,493 partici-
pants was 92.44 nmol/L and ranged from 12 to 319 nmol/L.
Thirteen participants (0.9 %) had serum 25(OH)D levels of
2570 Qual Life Res (2014) 23:2569–2575
123
\25 nmol/L, and 116 (7.8 %) had 25(OH)D levels
between 25 and 50 nmol/L (Table 1). Table 1 shows
prevalence of problems by vitamin D status for each of the
five EQ-5D dimensions and for any of these five problems.
Though there are some slight fluctuations, the percentages
of participants having problems in each of the five EQ-5D
dimensions generally declined with higher categories of
serum 25(OH) D. Table 1 also shows associations between
age, gender, income, and body weight and HRQOL. These
associations are mostly substantial in magnitude and sta-
tistically significant.
Table 2 shows the unadjusted and adjusted associations
between 25(OH)D levels and having problems in each of
the five EQ-5D dimensions. In the unadjusted analysis,
each 100 nmol/L increase in 25(OH)D was significantly
associated with a reduction in the odds of having problems
with mobility (39 %), usual activities (30 %), pain and
discomfort (26 %), and any problem (37 %). These asso-
ciations remained statistically significant after adjusting for
age and gender. Further, adjustment for income and body
weight reduced the magnitude of the associations and only
the association with anxiety or depression and any problem
remained statistically significant.
Figure 1 shows the mean values of HRQOL scores mea-
sured with EQ-5D-5L by vitamin D status. The mean HRQOL
scores increased with increasing levels of vitamin D. Table 3
shows unadjusted and adjusted associations between the log of
inverse HRQOL score and vitamin D levels, gender, age,
weight status, and income. After adjusting for gender, age,
weight status, and income, each 100 nmol/L increase in
vitamin D level was associated with a 0.15 (95 % CI 0.01,
0.29) statistically significant reduction in the log of inverse
HRQOL score, which corresponds to a statistically significant
increase in HRQOL score. A reduction in 0.15 in the log of
inverse HRQOL score (1 - HRQOL) is equivalent to an





given initial HRQOL score HRQOL0. Therefore, at a HRQOL
score of 0.5 a 100 nmol/L increase in 25(OH)D results in a
29 % increase in HRQOL score. The percentage increase is
higher than 29 % if the initial HRQOL score is below less 0.5
and\29 % if the initial HRQOL score is above 0.5.
Table 1 Prevalence of problems in the EQ-5D dimensions among 1,493 study participants













% p value % p value % p value % p value % p value % p value
25(OH)D level
\25 nmol/L 13 53.8 0.65 7.7 0.84 38.5 1.00 76.9 0.58 61.5 0.64 92.3 0.88
C25, \50 nmol/L 116 47.4 0.98 12.1 0.03 51.7 \.01 80.2 0.48 62.1 0.18 91.4 0.89
C50, \75 nmol/L 385 47.5 ref. 6.2 ref. 38.4 ref. 83.1 ref. 55.1 ref. 90.9 ref.
C75, \100 nmol/L 461 39.0 0.01 6.3 0.97 38.4 0.99 79.8 0.23 54.4 0.86 89.2 0.42
C100, \125 nmol/L 290 35.2 \.01 5.5 0.71 33.8 0.22 79.7 0.26 53.4 0.68 85.9 0.04
[125 nmol/L 228 34.2 \.01 7.5 0.56 35.1 0.41 78.9 0.21 49.1 0.15 86.0 0.06
Gender
Female 971 40.8 0.78 6.7 0.88 39.5 0.10 82.9 \.01 59.5 \.01 90.6 \.01
Male 522 40.0 ref. 6.9 ref. 35.2 ref. 76.1 ref. 44.4 ref. 85.1 ref.
Age (years)
50–59 356 36.2 \.01 5.9 \.01 40.4 0.01 82.3 0.70 65.7 \.01 91.9 0.38
60–69 687 38.9 \.01 5.1 \.01 34.2 \.01 80.5 0.99 53.9 0.16 88.2 0.93
70–79 363 43.0 \.01 8.0 \.01 38.8 \.01 78.8 0.72 45.7 0.97 86.5 0.60
80? 87 60.9 ref. 18.4 ref. 55.2 ref. 80.5 ref. 46.0 ref. 88.5 ref.
Income
Other 853 33.5 ref. 4.1 ref. 30.4 ref. 77.7 ref. 51.2 ref. 86.3 ref.




479 26.9 ref. 5.8 ref. 29.6 ref. 76.0 ref. 54.5 ref. 86.0 ref.
Overweight 593 40.5 \.01 5.2 0.69 36.9 0.01 80.8 0.05 52.6 0.54 89.4 0.08
Obesity 421 56.1 \.01 10.0 0.01 49.2 \.01 85.3 \.01 56.3 0.59 90.7 0.03
Ref.: reference category, 25(OH)D: serum 25-hydroxyvitamin D level, p value: Compared with the reference category
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Discussion
This is the first study to report on the associations of
vitamin D with each of the five dimensions of quality of
life. The study revealed significant associations of vitamin
D with problems with mobility, usual activities, and
depression and anxiety. It further revealed that an increase
of 100 nmol/L of serum 25(OH)D is associated with an
average increase of 29 % in HRQOL.
The average serum 25(OH)D level of participants was
92.44 nmol/L which is substantially higher than the aver-
age among Canadians aged 6 to 79 (67.7 nmol/L) and
among Canadians 60–79 years of age (72.0 nmol/L) [5].
Self-selection of health aware individuals interested to
participate in the wellness programme may have contrib-
uted to this. Health aware individuals may eat healthier and
comply better with the existing vitamin D supplementation
recommendations. This self-selection may particularly
apply to individuals with pain and discomfort. We
observed that approximately 80 % of participants reported
problems with pain and discomfort. This percentage seems
higher than those of a population-based survey using EQ-
5D-3L conducted in 2010 in the same province where
57 % of participants between the ages of 45 and 64 years
and 66 % of participants 65 years of age and older reported
problems with pain and discomfort [26]. Subjects experi-
encing pain and discomfort may be particularly motivated
to participant in the programme.
Gender and age are established determinants of vitamin
D status [6, 17] and of quality of life [20]. It is, therefore,
essential to adjust for the confounding influence of gender
and age as we did in this study. We observed that vitamin
D was associated with three of the five EQ-5D dimensions:
mobility, usual activities, and depression or anxiety. The
absence of a statistical significant association with self-care
may stem from the very low prevalence of reported prob-
lems with self-care in this population. Bias by indication
[27], whereby individuals with symptoms, pain, and illness
are more likely to comply with recommendations, may
have led to an underestimation of the strength of the
association with each of the five dimensions. However, this
may be particularly true for problems with ‘pain and
Table 2 Changes in the odds of each EQ-5D dimension problems per 100 nmol increase in 25(OH)D/L among 1,493 study participants
Problem Unadjusted Adjusted for age and gender Adjusted for age, gender,
income, and weight status
Odds ratio 95 % CI p value Odds ratio 95 % CI p value Odds ratio 95 % CI p value
Problems with mobility 0.61 0.46–0.80 \.01 0.58 0.44–0.78 \.01 0.82 0.61–1.10 0.18
Problems with self-care 0.89 0.52–1.53 0.68 0.88 0.51–1.52 0.65 1.11 0.65–1.91 0.70
Problems with usual activities 0.70 0.53–0.92 0.01 0.67 0.50–0.89 \.01 0.87 0.65–1.18 0.37
Problems with pain and discomfort 0.85 0.61–1.17 0.32 0.79 0.57–1.10 0.16 0.95 0.67–1.34 0.77
Problems with depression and anxiety 0.74 0.57–0.97 0.03 0.67 0.51–0.88 \.01 0.71 0.53–0.94 0.02
Any problem 0.63 0.43–0.91 0.02 0.58 0.39–0.84 \.01 0.66 0.44–0.98 0.04
CI confidence interval, 25(OH)D serum 25-hydroxyvitamin D level
Fig. 1 Mean HRQOL score by
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discomfort’ and explain why no association for this
dimension was observed.
Vitamin D has been shown to lead to better muscle
strength [28], and, both in observational studies and clini-
cal trials, vitamin D supplementation has been shown to
benefit mobility and functional status in terms of preven-
tion of falls [9] and improvement of physical function [29].
Consistent with our observations that individuals with a
better vitamin D status reported less problems with
mobility and usual activities, these findings [9, 29] seem to
suggest less frailty among individuals with a good vitamin
D status, though a recent meta-analysis reported that vita-
min D supplementation among unselected community-
dwelling individuals does not change risk for skeletal or
non-skeletal outcomes by more than 15 % [30].
Vitamin D has also been shown to be associated with less
depression [14] which seems consistent with our observa-
tion that higher vitamin D serum levels are associated with
less problems with depression and anxiety. Though the
associations with several outcomes are probable, more
research is needed for more convincing evidence [31],
which may particularly apply to mental health outcomes.
The Institute of Medicine recommendations are issued
to the general public, but no earlier study had reported on
the association between vitamin D and quality of life in a
general population. Though we conducted this in a
community sample, caution is warranted when it comes the
generalizing our findings as this sample may be self-
selected towards a health aware subpopulation with a rel-
atively high prevalence of problems with pain and dis-
comfort. Despite the large sample size, a second study
limitation relates to the small number of participants that
reported problems with self-care, which hampered some of
the analyses. Further, although we did adjust for the con-
founding effect of age, sex, income, and body weight sta-
tus, we acknowledge that other factors may have
confounded the observed association of 25(OH)D and
HRQOL. Further, limitations relate to the cross-sectional
design and the existence of reverse causation whereby, for
example, individuals with limited mobility due to chronic
diseases have less opportunity to get outdoors. A final
limitation relates to the use of self-reported information
that is prone to error, though the EQ-5D is an established
and validated instrument [19] whereby the reporting error
is expected to be limited given that it is short and easy to
complete [21].
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